Novo Nordisk, maker of weight-loss drug Wegovy, struck a deal with online telehealth storefronts that sold cheap knockoffs during shortages.
Our daily email brings you smart and engaging news and analysis on the biggest stories in business and finance. For free.
After a sharp spike in prices the past couple of years, chicken is finally experiencing some deflation thanks to the green energy industry.
After a top producer warned the world’s uranium production may start to slip, the price of the radioactive material started to soar.
Reducing beverage-wait times is part of Starbucks CEO Brian Niccol’s turnaround plan, which includes tech updates focused on efficiency.
The 10-year pact puts the king of streaming squarely in the sports livestreaming arena.
Boomers are ahead of younger generations in embracing from the Chinese e-commerce marketplace.
The retailer questioned how the proposed deal would be financed, but it may just be delaying the inevitable.
To prepare for a slowdown of global trade, US retailers spent months building a massive inventory to prevent empty shelves.
The old world of media is collapsing, while a new order is rising. Live sports, meanwhile, are caught in the middle.
Many of the medicines are the most popular in the sector, including popular weight loss drugs Ozempic and Mounjaro.
The budget airline’s fate is uncertain after a court ruled that its merger with JetBlue would harm consumers.
Canada’s Liberal Party won a majority promising to distance the country from the US, a major importer of Canadian crude.
Investor worries about a fresh batch of US tariffs have dragged LVMH shares in Paris down 23.6% so far this year.
The company plans to seek regulatory approval for the revolutionary weight loss treatment by the end of the year.
The warnings come as the industry adapts to seismic shifts in technology — which means it may just have some new tricks up its sleeve.